NO834160L - Antimykotisk middel i gelform til behandling av soppinfeksjoner i munnhulen - Google Patents

Antimykotisk middel i gelform til behandling av soppinfeksjoner i munnhulen

Info

Publication number
NO834160L
NO834160L NO834160A NO834160A NO834160L NO 834160 L NO834160 L NO 834160L NO 834160 A NO834160 A NO 834160A NO 834160 A NO834160 A NO 834160A NO 834160 L NO834160 L NO 834160L
Authority
NO
Norway
Prior art keywords
gel
antimycotic
former
treatment
hydroxypropyl cellulose
Prior art date
Application number
NO834160A
Other languages
English (en)
Norwegian (no)
Inventor
Miklos Von Bittera
Karl Heinz Buechel
Manfred Plempel
Erik Regel
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6178958&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO834160(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO834160L publication Critical patent/NO834160L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
NO834160A 1982-11-25 1983-11-14 Antimykotisk middel i gelform til behandling av soppinfeksjoner i munnhulen NO834160L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823243546 DE3243546A1 (de) 1982-11-25 1982-11-25 Antimykotische mittel in gelform zur behandlung von pilzinfektionen der mundhoehle

Publications (1)

Publication Number Publication Date
NO834160L true NO834160L (no) 1984-05-28

Family

ID=6178958

Family Applications (1)

Application Number Title Priority Date Filing Date
NO834160A NO834160L (no) 1982-11-25 1983-11-14 Antimykotisk middel i gelform til behandling av soppinfeksjoner i munnhulen

Country Status (12)

Country Link
EP (1) EP0112485B1 (xx)
JP (1) JPS59108712A (xx)
KR (1) KR840006766A (xx)
AT (1) ATE33759T1 (xx)
CA (1) CA1209920A (xx)
DE (2) DE3243546A1 (xx)
DK (1) DK538683A (xx)
ES (1) ES8502337A1 (xx)
GR (1) GR79726B (xx)
IL (1) IL70290A (xx)
NO (1) NO834160L (xx)
ZA (1) ZA838774B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4542020A (en) * 1984-08-17 1985-09-17 E. R. Squibb & Sons, Inc. Long-lasting adhesive antifungal suppositories
JPS61151117A (ja) * 1984-12-25 1986-07-09 Bayer Yakuhin Kk 抗真菌ゲル製剤
DE3614095A1 (de) * 1986-04-25 1987-10-29 Goedecke Ag Oxyalkylcellulose enthaltende gelzubereitung
US5093133A (en) * 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
JP2005097271A (ja) * 2003-08-20 2005-04-14 Matsumoto Shika Univ 抗真菌剤用組成物
US20050054583A1 (en) * 2003-08-20 2005-03-10 Matsumoto Dental University Composition for an antifungal agent for suppressing fungal growth in an oral cavity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL31756C (xx) * 1962-04-26
US4056611A (en) * 1973-04-16 1977-11-01 Stiefel Laboratories, Inc. Therapeutic composition
US4313765A (en) * 1980-09-24 1982-02-02 Merck & Co., Inc. Synergistic blends of cellulase-free xanthan gum and cellulosics
DE3045915A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
JPS57120576A (en) * 1981-01-20 1982-07-27 Sumitomo Chem Co Ltd Novel imidazole ester
DE3106635A1 (de) * 1981-02-23 1982-09-09 Bayer Ag Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften

Also Published As

Publication number Publication date
EP0112485B1 (de) 1988-04-27
DE3243546A1 (de) 1984-05-30
ES527514A0 (es) 1985-01-01
JPS59108712A (ja) 1984-06-23
DE3376386D1 (en) 1988-06-01
ZA838774B (en) 1984-07-25
ES8502337A1 (es) 1985-01-01
GR79726B (xx) 1984-10-31
EP0112485A3 (en) 1985-10-23
DK538683A (da) 1984-05-26
IL70290A0 (en) 1984-02-29
IL70290A (en) 1988-01-31
KR840006766A (ko) 1984-12-03
CA1209920A (en) 1986-08-19
ATE33759T1 (de) 1988-05-15
DK538683D0 (da) 1983-11-24
EP0112485A2 (de) 1984-07-04

Similar Documents

Publication Publication Date Title
EP1132081B1 (en) Process for preparing cellulose capsule using mixed solution of pectin and glycerin
TWI225401B (en) Solutions containing epinastin
JP2004504279A (ja) α−2−アドレナリンアゴニスト成分を含有する組成物
KR860009032A (ko) γ-사이클로 덱스트린 유도체의 제조방법
JP2006516032A5 (xx)
NO834160L (no) Antimykotisk middel i gelform til behandling av soppinfeksjoner i munnhulen
RU2019141996A (ru) Клеточная система и способ хранения клеток
JP3748970B2 (ja) ヒアルロン酸ナトリウム含有水溶液
KR20120125305A (ko) 장기 지속 안압 강하 효과를 지니는 알파?2 아드레날린 작용제
KR920011516A (ko) 약제학적 조성물
JPH0639379B2 (ja) 新規な製剤およびその調整方法
JP7254101B2 (ja) 複数回使用のトラセミド組成物
NO851772L (no) Fremgangsmaate til fremstilling av 2-amino-3-etoksy-krbonylamino-6-(p-fluor-benzylamino)-pyridin-glukonat samt injiserbare opploesninger inneholdende dette stoff.
US20220105045A1 (en) Pullulan empty hard capsule and preparation method therefor
WO2021101883A1 (en) Chitosan containing compositions and methods relating to same
US4128632A (en) Solubilization of Rafoxanide
JPS6084225A (ja) 点眼剤
Roy et al. Production of experimental scurvy in a bird species
Hanh et al. Development and evaluation of neem gel formulation using gum karaya as gelling agent
US2834777A (en) Methods of treating cellulose ethers
KR870004967A (ko) 무정형 벤즈 이미다졸 유도체
JPH01294633A (ja) 点眼剤
EP3463327B1 (en) Stabilization of beta-hydroxyisovaleric acid formulations in soft gel capsules
JPS6281319A (ja) 前眼部手術用の前房注入剤
KR100486089B1 (ko) 암프롤륨, 설파퀴녹살린, 및 에토파베이트를 함유하는액상제제의 제조방법